145 related articles for article (PubMed ID: 7525959)
1. Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: a mechanism for the apparent intercalator-induced inhibition of topoisomerase II.
McDonald LA; Eldredge GS; Barrows LR; Ireland CM
J Med Chem; 1994 Oct; 37(22):3819-27. PubMed ID: 7525959
[TBL] [Abstract][Full Text] [Related]
2. Additional cytotoxic pyridoacridine alkaloids from the ascidian Cystodytes violatinctus and biogenetic considerations.
Bontemps N; Gattacceca F; Long C; Thomas OP; Banaigs B
J Nat Prod; 2013 Sep; 76(9):1801-5. PubMed ID: 23961991
[TBL] [Abstract][Full Text] [Related]
3. Sebastianines A and B, novel biologically active pyridoacridine alkaloids from the Brazilian ascidian Cystodytes dellechiajei.
Torres YR; Bugni TS; Berlinck RG; Ireland CM; Magalhães A; Ferreira AG; Moreira Da Rocha R
J Org Chem; 2002 Jul; 67(15):5429-32. PubMed ID: 12126446
[TBL] [Abstract][Full Text] [Related]
4. Structures and antimicrobial activities of pyridoacridine alkaloids isolated from different chromotypes of the ascidian Cystodytes dellechiajei.
Bontemps N; Bry D; López-Legentil S; Simon-Levert A; Long C; Banaigs B
J Nat Prod; 2010 Jun; 73(6):1044-8. PubMed ID: 20491501
[TBL] [Abstract][Full Text] [Related]
5. Pyrroloquinoline and pyridoacridine alkaloids from marine sources.
Ding Q; Chichak K; Lown JW
Curr Med Chem; 1999 Jan; 6(1):1-27. PubMed ID: 9873113
[TBL] [Abstract][Full Text] [Related]
6. AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.
Marshall KM; Holden JA; Koller A; Kashman Y; Copp BR; Barrows LR
Anticancer Drugs; 2004 Oct; 15(9):907-13. PubMed ID: 15457132
[TBL] [Abstract][Full Text] [Related]
7. Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II.
Rosenzweig HS; Papadopoulou MV; Bloomer WD
Oncol Res; 2005; 15(4):219-31. PubMed ID: 17822282
[TBL] [Abstract][Full Text] [Related]
8. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
Larsen AK; Grondard L; Couprie J; Desoize B; Comoe L; Jardillier JC; Riou JF
Biochem Pharmacol; 1993 Oct; 46(8):1403-12. PubMed ID: 8240389
[TBL] [Abstract][Full Text] [Related]
9. Nordehydrocyclodercitin, a hexacyclic pyridoacridine alkaloid from the marine ascidian, Aplidium sp.
Agrawal MS; Bowden BF
Nat Prod Res; 2007 Jul; 21(9):782-6. PubMed ID: 17763101
[TBL] [Abstract][Full Text] [Related]
10. Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species.
Marshall KM; Andjelic CD; Tasdemir D; Concepción GP; Ireland CM; Barrows LR
Mar Drugs; 2009 May; 7(2):196-209. PubMed ID: 19597581
[TBL] [Abstract][Full Text] [Related]
11. Sagitol D, a New Thiazole Containing Pyridoacridine Alkaloid from a Vietnamese Ascidian.
Utkina NK
Nat Prod Commun; 2015 Sep; 10(9):1547-8. PubMed ID: 26594755
[TBL] [Abstract][Full Text] [Related]
12. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.
Wang L; Price HL; Juusola J; Kline M; Phanstiel O
J Med Chem; 2001 Oct; 44(22):3682-91. PubMed ID: 11606133
[TBL] [Abstract][Full Text] [Related]
13. Binding to DNA and cytotoxic evaluation of ascididemin, the major alkaloid from the Mediterranean ascidian Cystodytes dellechiajei.
Bonnard I; Bontemps N; Lahmy S; Banaigs B; Combaut G; Francisco C; Colson P; Houssier C; Waring MJ; Bailly C
Anticancer Drug Des; 1995 Jun; 10(4):333-46. PubMed ID: 7786398
[TBL] [Abstract][Full Text] [Related]
14. Cycloshermilamine D, a new pyridoacridine from the marine tunicate cystodytes violatinctus.
Koren-Goldshlager G; Aknin M; Kashman Y
J Nat Prod; 2000 Jun; 63(6):830-1. PubMed ID: 10869211
[TBL] [Abstract][Full Text] [Related]
15. Three new pyridoacridine type alkaloids from a singaporean ascidian.
Nilar N; Sidebottom PJ; Carté BK; Butler MS
J Nat Prod; 2002 Aug; 65(8):1198-200. PubMed ID: 12193032
[TBL] [Abstract][Full Text] [Related]
16. Chemical and Pharmacological Prospection of the Ascidian
Batista PJ; Nuzzo G; Gallo C; Carbone D; dell'Isola M; Affuso M; Barra G; Albiani F; Crocetta F; Virgili R; Mazzella V; Castiglia D; d'Ippolito G; Manzo E; Fontana A
Mar Drugs; 2024 Jan; 22(2):. PubMed ID: 38393046
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.
Kong XB; Rubin L; Chen LI; Ciszewska G; Watanabe KA; Tong WP; Sirotnak FM; Chou TC
Mol Pharmacol; 1992 Feb; 41(2):237-44. PubMed ID: 1311406
[TBL] [Abstract][Full Text] [Related]
18. Temporal variation in the production of four secondary metabolites in a colonial ascidian.
López-Legentil S; Bontemps-Subielos N; Turon X; Banaigs B
J Chem Ecol; 2006 Sep; 32(9):2079-84. PubMed ID: 16924427
[TBL] [Abstract][Full Text] [Related]
19. Marine pyridoacridine alkaloids and synthetic analogues as antitumor agents.
Delfourne E; Bastide J
Med Res Rev; 2003 Mar; 23(2):234-52. PubMed ID: 12500290
[TBL] [Abstract][Full Text] [Related]
20. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay.
Snyder RD; Arnone MR
Mutat Res; 2002 Jun; 503(1-2):21-35. PubMed ID: 12052500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
